Macleods Pharmaceuticals Ltd has recalled 1,344 bottles (1000-count each) of Levothyroxine Sodium Tablets, USP (112 mcg). The recall was initiated after a foreign substance—a black hair—was found embedded inside a tablet. This prescription medication is used to treat hypothyroidism and should meet strict purity standards.
The presence of a foreign object like a hair in a tablet is a manufacturing defect that poses a risk of contamination. While the immediate health risk is considered low, foreign material in prescription medication is a violation of safety and quality standards.
You have 2 options:
Manufactured for Macleods Pharma USA, Inc. Princeton, NJ; Manufactured by Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.